Guideline authors discussed therapeutic options for patients with hand, knee and hip OA in a session at the 2019 ACR/ARP Annual Meeting.
Search results for: hip
New ARP President Janet Poole, PhD, OTR/L, FAOTA, Plans to Build Membership & Address Workforce Shortages
Dr. Poole’s cited priorities include building an interprofessional membership team through developing resources and promoting rheumatology to health professionals in many disciplines.
What Causes Knee, Hip & Hand Osteoarthritis
Funck-Brentano et al. hypothesized that causal associations for osteoarthritis (OA) may differ by site, and they undertook this study to identify causal risk factors of knee, hip and hand OA.
How to Cultivate Stronger Mentor–Mentee Relationships
An experienced mentor shares his tips for how to support rheumatology professionals who are learning the art of rheumatologic care early in their careers…
Fellowship Success 101: Focus on These 5 Areas
“Congratulations! You have matched!” With Match Day in the rearview mirror and residency nearing an end, incoming fellows prepare for the next road trip on their journey to becoming a rheumatologist. Residency molds new graduates into competent physicians by providing an overview of general medicine and teaching them the clinical and professional skills necessary to…
Exercise Therapy Benefits Patients with Knee & Hip OA
A meta-analysis confirms prior research suggesting exercise therapy benefits patients with knee and hip osteoarthritis (OA). The study found greater improvements in pain, function, performance and quality of life in patients with milder, as opposed to more severe, OA…
Email & Text in the World of HIPAA
The world we live in necessitates information be communicated in a quick and easy manner. This remains true in the healthcare setting. The ability to text or email staff and patients has become a priority for many healthcare entities. However, maintaining patient privacy and confidentiality is essential to ensure we meet compliance standards. Although emailing…
Update on Accelerating Medicines Partnership
The Accelerating Medicines Partnership (AMP) was launched in 2014 as a public-private partnership to spur development of new therapeutic options for rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Five years in, this unprecedented public-private effort is achieving its major milestones and yielding tools to accelerate potential new drug discoveries. The Rheumatology Research Foundation is…
At Vasculitis Conference, Patients Share Hope, Humor & Hardships
SEATTLE—At the first regional vasculitis patient conference ever held in the Pacific Northwest, a panoramic view of Mt. Rainier on a clear January morning set the tone for a day of optimistic talks about recent successes against the various forms of blood vessel inflammation. One attendee at the Jan. 12 conference, sponsored by the Vasculitis…
Insights on the Diagnosis & Treatment of Low Back & Hip Pain
CHICAGO—Two experts presented insights on the diagnosis and treatment of low back and hip pain, including a refresher course on the mechanical structures involved, in Anatomy in a Day: Demystifying Low Back Pain and Lateral Hip Pain: New Patho-Anatomical Perspectives, a session at the 2018 ACR/ARHP Annual Meeting. Low Back Pain Avoid using such terms…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 343
- Next Page »